These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Effect of fenofibrate treatment on plasma lipoprotein lipids, high-density lipoprotein cholesterol subfractions, and apolipoproteins B, AI, AII, and E. Knopp RH; Walden CE; Warnick GR; Albers JJ; Ginsberg J; McGinnis BM Am J Med; 1987 Nov; 83(5B):75-84. PubMed ID: 3120587 [TBL] [Abstract][Full Text] [Related]
9. Effects of fenofibrate on high and low density lipoprotein metabolism in heterozygous familial hypercholesterolemia. Malmendier CL; Delcroix C Atherosclerosis; 1985 May; 55(2):161-9. PubMed ID: 3924068 [TBL] [Abstract][Full Text] [Related]
10. Integrated regulation of very low density lipoprotein triglyceride and apolipoprotein-B kinetics in man: normolipemic subjects, familial hypertriglyceridemia and familial combined hyperlipidemia. Kissebah AH; Alfarsi S; Adams PW Metabolism; 1981 Sep; 30(9):856-68. PubMed ID: 7266376 [TBL] [Abstract][Full Text] [Related]
11. Preferential reduction of very low density lipoprotein-1 particle number by fenofibrate in type IIB hyperlipidemia: consequences for lipid accumulation in human monocyte-derived macrophages. Milosavljevic D; Griglio S; Le Naour G; Chapman MJ Atherosclerosis; 2001 Mar; 155(1):251-60. PubMed ID: 11223449 [TBL] [Abstract][Full Text] [Related]
12. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss. Ginsberg HN; Le NA; Gibson JC J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021 [TBL] [Abstract][Full Text] [Related]
14. Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. Watts GF; Barrett PH; Ji J; Serone AP; Chan DC; Croft KD; Loehrer F; Johnson AG Diabetes; 2003 Mar; 52(3):803-11. PubMed ID: 12606523 [TBL] [Abstract][Full Text] [Related]
15. A multicenter comparison of the effects of simvastatin and fenofibrate therapy in severe primary hypercholesterolemia, with particular emphasis on lipoproteins defined by their apolipoprotein composition. Bard JM; Parra HJ; Camare R; Luc G; Ziegler O; Dachet C; Bruckert E; Douste-Blazy P; Drouin P; Jacotot B Metabolism; 1992 May; 41(5):498-503. PubMed ID: 1588829 [TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia in postmenopausal women. Metabolic defects and response to low-dose lovastatin. Arca M; Vega GL; Grundy SM JAMA; 1994 Feb; 271(6):453-9. PubMed ID: 8295321 [TBL] [Abstract][Full Text] [Related]
17. Two patterns of LDL metabolism in normotriglyceridemic patients with hypoalphalipoproteinemia. Vega GL; Grundy SM Arterioscler Thromb; 1993 Apr; 13(4):579-89. PubMed ID: 8466893 [TBL] [Abstract][Full Text] [Related]
18. Influence of simvastatin, fenofibrate and/or ezetimibe on correlation of low-density lipoprotein and nonhigh-density lipoprotein cholesterol with apolipoprotein B in mixed dyslipidemic patients. Farnier M; Taggart W; Dong Q; Lin J; Shah A; Brudi P J Clin Lipidol; 2011; 5(3):179-187. PubMed ID: 21600523 [TBL] [Abstract][Full Text] [Related]
19. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia. Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447 [TBL] [Abstract][Full Text] [Related]